Lv1
50 积分 2021-08-09 加入
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
2个月前
已完结
IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab
7个月前
已完结
FRI0394 Efficacy and safety of canakinumab in gouty arthritis patients with chronic kidney disease stage ≥3:
7个月前
已完结
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
7个月前
已关闭
Recent advances and evolving concepts in Still’s disease
7个月前
已完结
Biologics first: evidence reshaping Still's disease treatment
7个月前
已完结
The use of IL-1 and IL-6 inhibitors should be prioritised in Still's disease
7个月前
已关闭
Global, Regional, and National Burden of Vertebral Fractures Due to Falls from 1990 to 2021 and Predictions for the Next 15 Years: A Systematic Analysis of the Global Burden of Disease 2021 Study
9个月前
已完结
Biomarkers for Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced/Metastatic Breast Cancer: Translation to Clinical Practice
10个月前
已完结
Clinical characteristics of adolescent-onset gout in Chinese: A hospital-based cross-sectional study
11个月前
已完结
皖公网安备34019202002308
